BOULDER, Colo. (AP) — Brickell Biotech, Inc. (BBI) on Thursday reported a loss of $4.3 million in its third quarter.

On a per-share basis, the Boulder, Colorado-based company said it had a loss of 15 cents.

The drug developer posted revenue of $142,000 in the period.

In the final minutes of trading on Thursday, the company's shares hit 54 cents. A year ago, they were trading at $2.15.


This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on BBI at

Copyright by Automated Insights, Inc. All rights reserved.

(0) comments

Welcome to the discussion.

Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article.